U.S. House Energy & Commerce party leaders recently announced new committee members.

House E&C Leaders Announce Leadership Team and New Committee Members

U.S. House Energy and Commerce (E&C) Chair Frank Pallone (D-N.J.) last Friday formally announced Rep. Anna Eshoo (D-Calif.) as Health subcommittee chair and Rep. Diana DeGette (D-Colo.) as leader of the Oversight and Investigations subcommittee.

Eshoo, who is based in a Northern California district with a large biotechnology presence, is considered to be largely an ally of the pharmaceutical industry. However, she has not supported the drug industry’s efforts to reign in the 340B program. DeGette has been more active in the 340B arena. She recently co-spearheaded a bipartisan letter to now former U.S. Health and Human Services (HHS) Secretary Azar signed by 243 members of Congress, calling on the department to penalize drug manufacturers for restricting or prohibiting access to 340B discounts at contract pharmacies. DeGette could end up holding hearings on the matter in the new session of Congress.

U.S. House Energy and Commerce (E&C) Chair Frank Pallone (D-N.J.) last Friday formally announced Rep. Anna Eshoo (D-Calif.) as Health subcommittee chair and Rep. Diana DeGette (D-Colo.) as leader of the Oversight and Investigations subcommittee.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report